NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£18M
Sector
HEALTH
Published
11 Jun 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

North East England: ITT lists Purchasing Points. Framework intended for use by the NHS in England, Scotland Northern Ireland, Dept of Health & Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). The framework will commence on 1 June 2021 for a period of 7 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.

Total Quantity or Scope

Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months.

Award Detail

1 Octapharma (Manchester)
  • Reference: 013184-2021-1
  • Value: £17,595,000

Renewal Options

Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.

Award Criteria

price _

CPV Codes

  • 33651520 - Immunoglobulins

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains